The chairs of six parliamentary committees have asked the National Audit Office (NAO) to look into whether the pharmaceutical ...
The extension of the UK Rare Diseases Framework represents both progress and unfinished business. When it launched in 2021, the framework set out a shared ambition to address structural inequities ...
Since the approval of semaglutide (Wegovy; Novo Nordisk) as a weight-loss injection in the United States in 2021, the effect of GLP-1 medicines on the treatment of obesity has been undeniable. In the ...
More than half of integrated care systems (ICSs) do not commission enough tests for childhood asthma, information gathered by charity Asthma + Lung UK has shown. Of 37 ICSs who responded to a survey ...
Women with incurable breast cancer can now receive Enhertu (trastuzumab deruxtecan, Daiichi Sankyo) on the NHS in England, under final draft guidance from the National Institute for Health and Care ...
The UK government has said it will work to develop a “clear and scalable programme of psychological support” that could be rolled out if another pandemic occurs. Responding to recommendations made by ...
The All Wales Medicines Strategy Group (AWMSG) has recommended EURneffy, a 2mg nasal adrenaline spray, for the emergency treatment of anaphylaxis in NHS Wales. The recommendation applies to adults and ...
Access to insulin in NHS neonatal units should be restricted using digital devices, with CCTV installed on storage units in the meantime, the Thirlwall Inquiry has recommended. The inquiry, ...
The number of Fitness to Practise (FtP) concerns raised rose by around one-third in 2025–2026 compared with the year before, the General Pharmaceutical Council (GPhC) has said, noting a “sharp ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results